检索结果 - Carter, Jori

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Cervical Cancer Tests and Treatment

    Cervical Cancer Tests and Treatment 由 Carter, Jori S., Downs, Levi S.

    出版 2011
    获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  2. 2
    Ovarian Cancer Tests and Treatment

    Ovarian Cancer Tests and Treatment 由 Carter, Jori S., Downs, Levi S.

    出版 2011
    获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  3. 3
    A prospective clinical trial of lenalidomide with topotecan in women with advanced epithelial ovarian carcinoma

    A prospective clinical trial of lenalidomide with topotecan in women with advanced epithelial ovarian carcinoma 由 Carter, Jori S., Downs, Levi S.

    出版 2011
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  4. 4
    Idiopathic Adrenal Hemorrhage in a Patient with Gestational Trophoblastic Neoplasia

    Idiopathic Adrenal Hemorrhage in a Patient with Gestational Trophoblastic Neoplasia 由 Carter, Jori S., Kothari, Rajul, Jonson, Amy L.

    出版 2011
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  5. 5
    Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: a case report and review of the literature

    Antiestrogen therapy in recurrent ovarian cancer resulting in 28 months of stable disease: a case report and review of the literature 由 Kothari, Rajul, Argenta, Peter, Fowler, Jeffrey, Carter, Jori, Shimp, William

    出版 2010
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  6. 6
    Necrotizing fasciitis after placement of intraperitoneal catheter()

    Necrotizing fasciitis after placement of intraperitoneal catheter() 由 Carter, Jori S., Hutto, Sarah L., Asghar, Javariah I., Teoh, Deanna G.K.

    出版 2013
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  7. 7
    Increasing Age Predicts Poor Cervical Cancer Prognosis with Subsequent Effect on Treatment and Overall Survival

    Increasing Age Predicts Poor Cervical Cancer Prognosis with Subsequent Effect on Treatment and Overall Survival 由 Quinn, Bridget A., Deng, Xiaoyan, Colton, Adrianne, Bandyopadhyay, Dipankar, Carter, Jori, Fields, Emma C.

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  8. 8
    OSU‐03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood–Brain Barrier: Implications for Anti‐Cancer Therapies

    OSU‐03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood–Brain Barrier: Implications for Anti‐Cancer Therapies 由 Booth, Laurence, Roberts, Jane L., Tavallai, Mehrad, Nourbakhsh, Aida, Chuckalovcak, John, Carter, Jori, Poklepovic, Andrew, Dent, Paul

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  9. 9
    Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance

    Celecoxib enhances [sorafenib + sildenafil] lethality in cancer cells and reverts platinum chemotherapy resistance 由 Webb, Timothy, Carter, Jori, Roberts, Jane L, Poklepovic, Andrew, McGuire, William P, Booth, Laurence, Dent, Paul

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  10. 10
    QUANTITATIVE MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING OF OVARIAN CANCER

    QUANTITATIVE MULTI-PARAMETRIC MAGNETIC RESONANCE IMAGING OF OVARIAN CANCER 由 Carter, Jori S., Koopmeiners, Joseph S., Kuehn-Hajder, Jessica E., Metzger, Gregory J., Lakkadi, Navneeth, Downs, Levi S., Bolan, Patrick J.

    出版 2013
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  11. 11
    WATER-FAT MR IMAGING FOR ASSESSING CHANGES IN BONE MARROW COMPOSITION DUE TO RADIATION AND CHEMOTHERAPY IN GYNECOLOGIC CANCER PATIENTS

    WATER-FAT MR IMAGING FOR ASSESSING CHANGES IN BONE MARROW COMPOSITION DUE TO RADIATION AND CHEMOTHERAPY IN GYNECOLOGIC CANCER PATIENTS 由 Bolan, Patrick J., Arentsen, Luke, Sueblinvong, Thanasak, Zhang, Yan, Moeller, Steen, Carter, Jori S., Downs, Levi S., Ghebre, Rahel, Yee, Douglas, Froelich, Jerry, Hui, Susanta

    出版 2013
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  12. 12
    A phase I–II evaluation of veliparib (NSC#737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: An NRG Oncology/Gynecologic Oncology Group study

    A phase I–II evaluation of veliparib (NSC#737664), topotecan, and filgrastim or pegfilgrastim in the treatment of persistent or recurrent carcinoma of the uterine cervix: An NRG On... 由 Kunos, Charles, Deng, Wei, Dawson, Dawn, Lea, Jayanthi S., Zanotti, Kristine M., Gray, Heidi J., Bender, David P., Guaglianone, Perry P., Carter, Jori S., Moore, Kathleen N.

    出版 2015
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:

检索工具: